The subject matter described herein relates to an injection site information cap and method for use in providing information to recordkeeping systems to automatically document caregiver identification, patient care activity, and/or procedural steps in the use of and/or care of a medication injection site.
Many health care procedures involve IV medication administrations. The type of medication and timing of administration are important to record in order to provide healthcare providers real-time information on the conduct of the procedure and the completion of a medical record. Some protocols require quick medication administrations with limited time for documentation and record keeping. Others require completion and verification of medication administration manually to ensure proper patient care and accounting for use of medications.
Injectable medications and fluids are frequently utilized by healthcare providers (caregivers) in the care of patients in the hospital, in pre-hospital emergency medical services (EMS) and at alternate care sites (including skilled nursing facilities, home health and hospice settings). Caregivers can include medical doctors, registered nurses, EMS paramedics, dentists and other licensed healthcare practitioners. Accurate documentation of what, when and how much medication and/or IV fluid is given to a patient is required by healthcare institutions, governmental agencies and regulatory oversight agencies. This is especially true when the IV fluid being administered to the patient is a medication or blood product. The type of IV fluid and the timing of administration are important to record in order to provide healthcare providers real-time information on the conduct of the procedure and the completion of a medical record. Some protocols require quick IV fluid administrations with limited time for documentation and record keeping. Others require completion and verification of manually administered IV fluids to ensure proper patient care and accounting for use of IV fluids.
Additionally, to ensure proper patient safety and limit exposure to catheter-related bloodstream infections (CRBSI), vascular access ports (injection sites) require careful disinfection and careful management of the patient's IV site for patency. Absent these activities, needleless injection sites can become contaminated and patient vascular access can become infiltrated or blocked. When these situations occur, patient safety is compromised resulting in infection, pain, longer hospital stays and even death. Hospital costs for continued patient care increase and are not reimbursed by third party payers.
New automated documentation systems for medication administrations will likely help in the tracking of medication injections, but none have addressed the documentation of proper IV site care and the management of needleless injection sites for infection control or IV site for patency. Manual use of alcohol swabs or sterile caps containing a disinfectant solution are gaining popularity for disinfecting IV injection sites and controlling CRBSI. When caps are left attached to IV luer access needless valves they can disinfect and protect the IV site. To date, these activities are often not documented, rarely time tracked and even less likely to be identified by caregiver.
Other patient care activity and procedural steps such as obtaining lab samples, assisting in respiratory therapy, dietary management also require timely documentation. Manual documentation often results in accuracy errors, missed notations and undocumented activity due to fast paced patient care with limited resources. A better system could result in less error, increased billing accuracy, reduced paperwork and more time for caregivers to focus on patient care. Tracking of who did what and when at the point of care can be improved.
In one aspect, an injection site information cap includes a housing, a cover portion, an engagement portion configured to couple to and cover an injection port of an injection site and at least one information element on the cover portion that is positioned to be automatically sensed by at least one sensor of the injection site when the engagement portion is coupled to or is being coupled to the medication injection port.
The engagement portion can include a female luer lock thread configured to be coupled to a male luer lock thread on the injection port.
The at least one information element can be encoded with one or more of: mechanically encoded information, magnetically encoded information, a near field communication (NFC) tag, and a radio frequency identification (RFID) tag.
The at least one information element can include optically encoded information. The optically encoded information can include at least one bar code. The at least one bar code can be sensed by the at least one sensor as the cover portion is circumferentially rotated or translated linearly on the axial centerline of the luer lock.
The injection site information cap can include a disinfectant to disinfect the injection port upon the coupling of the engagement portion with the injection port. The engagement portion can be further configured to seal the injection port of the injection site.
The injection port can be fluidically coupled to a patient and/or to a fluid wasting reservoir.
The information element can encapsulate data characterizing one or more of: a disinfection state of the injection port, a caregiver identification, an identification of a patient, a procedural step performed in connection with care of the patient, a state of waste disposal, a lab sample, respiratory management for the patient, and dietary management for the patient.
Some or all of the housing can be color coded with one of a plurality of color categories. Each color category can characterize one or more of: caregiver identification, a patient care procedural activity, a laboratory sample, a state of the injection port, a fluid injected into the injection port, and a state of a patient. The at least one sensor or a different sensor can, in some variations, detect the color. In addition, in some variations, at least the information element is color coded with one of a plurality of color categories, each color category characterizing one or more of: care giver identification, a patient care procedural activity, a laboratory sample, a state of the injection port, a fluid injected into the injection port, and a state of a patient.
The information element can be affixed to an outer surface of the cover portion or it can be integral to an outer surface of the cover portion.
In a further aspect, an injection site information cap can include multiple engagement portions. For example, a medication injection site can comprise a housing including a first engagement portion on the housing configured to couple to and cover a first injection port of a first injection site. At least one first information element on an outer surface of the first engagement portion of the housing can be positioned to be automatically sensed by at least one first sensor of the first injection site when the first engagement portion is coupled to or is being coupled to the first injection port, a second engagement portion on the housing can be configured to couple to and cover a second injection port of a second injection site, and at least one second information element on an outer surface of the second engagement portion of the housing can be positioned to be automatically sensed by at least one second sensor of the second injection site when the second engagement portion is coupled to or is being coupled to the second injection port.
The at least one of the first engagement portion and the second engagement portion can comprises a female luer lock thread configured to couple to a male luer lock thread on the injection port. The at least one first information element and the at least one second information element can be encoded with one or more of: mechanically encoded information, magnetically encoded information, a near field communication (NFC) tag, and a radio frequency identification (RFID) tag. The at least one second information element can be optically encoded information. The optically encoded information can be at least one bar code. The at least one bar code can be sensed by the at least one sensor as the housing is circumferentially rotated.
The information cap can further comprise: a disinfectant to disinfect at least one of the first injection port upon the coupling of the first engagement portion to the first injection port. The at least one of the first injection port and the second injection port can be fluidically coupled to a patient. The at least one of the first injection port and the second injection port can be fluidically coupled to a fluid wasting reservoir.
The injection site information cap can include one or more of the at least one first information element and the at least one second information element to encapsulate data characterizing one or more of: a disinfection state of the injection port, a caregiver identification, an identification of a patient, a procedural step performed in connection with care of the patient, a state of waste disposal, a lab sample, respiratory management for the patient, and dietary management for the patient. The information cap can include at least a portion of the housing, and/or the information element, to be color coded with one of a plurality of color categories, each color category characterizing one or more of: caregiver identification, a patient care procedural activity, a laboratory sample, a state of the injection port, a fluid injected into the injection port, and a state of a patient.
The one or more of the at least one first information element and the at least one second information element can be affixed to an outer surface of the housing. The at least one first information element and the at least one second information element can be integral to an outer surface of the housing. The at least one of the first engagement portion and the second engagement portion can be further configured to seal and/or cover the injection port of the injection site. The first injection site and the second injection site can be physically connected to each other.
In some variations, the at least one first information element is different from the at least one second information element while in other variations the elements are the same (identical). Each engagement portion can have identical features such as disinfectant or they can differ (one side has disinfectant while the other does not). The housing can be color coded in different manners similar to a single engagement portion injection cap.
The first engagement portion can be positioned opposite the second engagement portion. In other variations, the first engagement portion is positioned at an angle or otherwise askew as compared to a center line of the second engagement portion. In other variations, the housing can be flexible.
In a further interrelated aspect, an apparatus includes a first engagement portion on the housing configured to cover a injection port, at least one first information element on an outer surface of the first engagement portion of the housing positioned to be automatically sensed by at least one first sensor of the injection site when the first engagement portion is coupled to or is being coupled to the injection port; a second engagement portion on the housing configured to cover the injection port, and at least one second information element on an outer surface of the second engagement portion of the housing positioned to be automatically sensed by at least one sensor of the injection site when the second engagement portion is coupled to or is being coupled to the injection port.
The injection site information caps as described herein can be used in connection with various methods. For example, one method can include receiving information from a medication delivery apparatus characterizing at least one information element on a cap covering an injection port of the medication delivery apparatus, associating the received information with data comprising one or more of: a disinfection state of the injection port, a caregiver identification, an identification of a patient, a procedural step performed in connection with care of the patient, a state of waste disposal, a lab sample, respiratory management for the patient, and dietary management for the patient, and promoting the associated data.
The medication delivery apparatus (injection site) can include a housing, a fluid conduit at least partially extending within the housing and configured to deliver medication within a medication container to the patient, an injection port extending from an external surface of the housing and configured to be coupled to a fluid outlet of the medication container (the medication port being fluidically and directly coupled to the fluid conduit), and at least one sensor disposed within the housing to sense the at least one information element on the information cap. In some variations, the medication delivery apparatus can also include a transmitter within the housing to wirelessly transmit information generated by the at least one sensor to a remote data collection system, and a self-contained power source within the housing powering the at least one sensor and the transmitter.
Promoting the associated data can include one or more of: displaying the associated data, storing the associated data into a physical storage device, loading the associated data into memory, and transmitting the associated data to a remote computing system.
Computer program products are also described that comprise nontransitory computer readable media storing instructions, which when executed one or more data processor of one or more computing systems, causes at least one data processor to perform operations herein. Similarly, computer systems are also described that may include one or more data processors and a memory coupled to the one or more data processors. The memory may temporarily or permanently store instructions that cause at least one processor to perform one or more of the operations described herein. In addition, methods can be implemented by one or more data processors either within a single computing system or distributed among two or more computing systems. Such computing systems can be connected and can exchange data and/or commands or other instructions or the like via one or more connections, including but not limited to a connection over a network (e.g. the Internet, a wireless wide area network, a local area network, a wide area network, a wired network, or the like), via a direct connection between one or more of the multiple computing systems, etc.
The subject matter described herein provides many advantages. For example, the current subject matter allows for compact injection port systems that automatically identify activity at the injection site. The fluid injection port is sufficiently small to be placed on a standard IV line (and to be self-supporting) allowing it to be used in multiple situations including on-site paramedic treatments, during ambulance delivery of patients, as well as medical facilities such as emergency rooms/intensive care units/operating rooms/general care. Moreover, as medical staff (e.g., doctors, nurses, paramedics, etc.) are accustomed to handling Y-sites on IV lines and the current subject matter requires little, if any, behavior modifications while allowing for intelligent logging of patient care activities within normal workflow. In addition, the compact nature of the fluid injection port obviates the need for a larger tabletop or cradle bar code unit which can be cumbersome during code blue or other emergency events and which can require much needed space (displacing other required equipment). In addition, the current subject matter utilizes a wireless interface and does not require wires for communication of information to a data collection system which could interfere with or complicate patient care activity. Data received by the data collection system can be actively displayed in real-time providing clearly visible information to the medical staff keeping all informed and up-to-date. Furthermore, the current subject matter reduces manual record keeping and other activities that can tend to detract from the needed attention to a patient. Automated record keeping provides accurate records and frees up the health care provider's time enabling improved patient care.
The details of one or more variations of the subject matter described herein are set forth in the accompanying drawings and the description below. Other features and advantages of the subject matter described herein will be apparent from the description and drawings, and from the claims.
The accompanying drawings, which are incorporated in and constitute a part of this specification, show certain aspects of the subject matter disclosed herein and, together with the description, help explain some of the principles associated with the disclosed embodiments. In the drawings:
Like reference symbols in the various drawings indicate like or similar elements.
This application relates to each of the following applications, which are all entitled “Medication Injection Site and Data Collection System”: U.S. patent application Ser. No. 13/777,964 filed Feb. 26, 2013, which is a continuation-in-part of U.S. patent application Ser. No. 13/777,831 filed on Feb. 26, 2013, which in turn is a continuation-in-part of U.S. patent application Ser. No. 12/938,300 filed on Nov. 2, 2010, which in turn is a continuation-in-part of U.S. patent application Ser. No. 12/765,707 filed on Apr. 22, 2010, which in turn is a continuation-in-part of U.S. patent application Ser. No. 12/614,276 filed on Nov. 6, 2009; and additionally, priority is also claimed to U.S. Pat. App. Ser. No. 61/370,974 filed on Aug. 5, 2010. Each of the aforementioned patent applications are hereby fully incorporated by reference.
Additionally, this application relates to each of the following applications, which are entitled “Medication Container Encoding, Verification, and Identification”: U.S. patent application Ser. No. 13/671,752 filed Nov. 8, 2012, which is a continuation-in-part of U.S. patent application Ser. No. 13/149,782 filed on May 31, 2011. Each of the aforementioned patent applications are hereby fully incorporated by reference.
In addition to system 3 for encoded medication containers as shown in
Information cap 200 can be colored to designate a category. The color can be part of housing 5, part of information element 24 (background color) or part of data element 12. Categories can include any assigned color or type. For example color assignments could be: red=lab sample taken, orange=caregiver ID, yellow=medication given, green=billing charge, blue=physical therapy activity, violet=lab sample taken, white=sedation activity. Other colors and/or categories can be included. The color can be detected by identification sensor 18 and transmitted to the data collection system in addition to the information contained in the information element. The information can be detected by identification sensor 18 when a specific wavelength light (ultraviolet, infrared, etc), a specific RF or magnetic frequency, or a combination of frequency and wavelength is emitted from emitter 31.
Information cap 200 can be used with intelligent injection site 4 for caregiver identification during medication waste disposal. In this use case, intelligent injection site 4 can be connected to a medication waste disposal receptacle. Information cap 200 can contain caregiver ID information and document who and when medication waste is disposed. This can be followed by an encoded medication container and injection of waste medication into the receptacle. Fluid delivery sensor 60 can measure the volume of waste disposed. A second caregiver can verify waste disposal by immediately following waste disposal with the attachment of a second information cap 200 having a different caregiver ID. Information detected on caregivers information caps 200 and encoded medication container waste disposed volume can be transmitted 36 to data collection system 6, time stamped and transmitted 50 to medical information system 52.
Information element 24 on information cap 200 can be any one or more of: mechanically encoded information, magnetically encoded information, a near field communication (NFC) tag, a radio frequency readable information (RFID tag). The information element 24 can also or alternatively comprise optically encoded information and the identification sensor 18 can comprise an optical emitter and an optical detector to read the optically encoded information. The identification sensor 18 can include an optical emitter LED to illuminate the information element 24 and an optical detector such as a camera (charge coupled device—CCD). The identification sensor 18 can read information from the information element 24 as a result of relative motion of the information cap relative to injection site 4. The identification sensor 18 can read information from the information element 24 in response to mechanically coupling the information cap 200 to the injection site 4.
Information cap 200 can carry an information element 24 that provides detectable information indicative of an activity performed by a caregiver or a patient. The activity can be any one or more of: disinfection of the injection site, caregiver identification (name, ID number, employee number), a procedural step performed (IV site visual assessment, a surgical procedure step, an intensive care unit activity, an emergency medical services {EMS} activity), confirmation of waste disposal (unused controlled substances, contaminated waste, etc.), other patient care activity such as obtaining a lab sample from a patient, assisting in respiratory therapy of a patient, dietary management of a patient, and many other patient care activities at home, in the field, or in a hospital environment where recordation is appropriate. The data encapsulated by element 24 can be detected by an intelligent injection site and processed either locally or by transmitting to a remote computing system.
The identification sensor 18 can include an optical emitter/detector pair 31 that detects encoded information contained on information element 24 (a sleeve or label wrapped around injection site information cap 100). The identification sensor 18 can comprise a plurality of sensors to detect information element 24. In some variations, the identification sensors can be sensors such as optical, magnetic, mechanical, conductive, switchable RFID and/or proximity sensors. In other variations, identification sensor 18 can be optical and can include an illumination source (emitter) such as an LED and a detection source (detector) such as a camera (CCD). Sensor circuit 30 can provide signal processing and connects identification sensor 18 to transmitter 34. The identification sensor 18 can be directly coupled to power source 19.
Aspects of the subject matter described herein can be embodied in systems, apparatus, kits (e.g., kits with the medication injection site being enclosed therein), methods, and/or articles depending on the desired configuration. In particular, aspects of the subject matter described herein can be realized in digital electronic circuitry, integrated circuitry, specially designed ASICs (application specific integrated circuits), computer hardware, firmware, software, and/or combinations thereof. These various implementations can include implementation in one or more computer programs that are executable and/or interpretable on a programmable system including at least one programmable processor, which can be special or general purpose, coupled to receive data and instructions from, and to transmit data and instructions to, a storage system, at least one input device, and at least one output device.
These computer programs, which can also be referred to programs, software, software applications, applications, components, or code, include machine instructions for a programmable processor, and can be implemented in a high-level procedural language, an object-oriented programming language, a functional programming language, a logical programming language, and/or in assembly/machine language. As used herein, the term “machine-readable medium” refers to any computer program product, apparatus and/or device, such as for example magnetic discs, optical disks, memory, and Programmable Logic Devices (PLDs), used to provide machine instructions and/or data to a programmable processor, including a machine-readable medium that receives machine instructions as a machine-readable signal. The term “machine-readable signal” refers to any signal used to provide machine instructions and/or data to a programmable processor. The machine-readable medium can store such machine instructions non-transitorily, such as for example as would a non-transient solid state memory or a magnetic hard drive or any equivalent storage medium. The machine-readable medium can alternatively or additionally store such machine instructions in a transient manner, such as for example as would a processor cache or other random access memory associated with one or more physical processor cores.
To provide for interaction with a user, the subject matter described herein can be implemented on a computer having a display device, such as for example a cathode ray tube (CRT) or a liquid crystal display (LCD) monitor for displaying information to the user and a keyboard and a pointing device, such as for example a mouse or a trackball, by which the user may provide input to the computer. Other kinds of devices can be used to provide for interaction with a user as well. For example, feedback provided to the user can be any form of sensory feedback, such as for example visual feedback, auditory feedback, or tactile feedback; and input from the user may be received in any form, including, but not limited to, acoustic, speech, or tactile input. Other possible input devices include, but are not limited to, touch screens or other touch-sensitive devices such as single or multi-point resistive or capacitive trackpads, voice recognition hardware and software, optical scanners, optical pointers, digital image capture devices and associated interpretation software, and the like.
The subject matter described herein may be implemented in a computing system that includes a back-end component (e.g., as a data server), or that includes a middleware component (e.g., an application server), or that includes a front-end component (e.g., a client computer having a graphical user interface or a Web browser through which a user may interact with an implementation of the subject matter described herein), or any combination of such back-end, middleware, or front-end components. The components of the system may be interconnected by any form or medium of digital data communication (e.g., a communication network). Examples of communication networks include a local area network (“LAN”), a wide area network (“WAN”), and the Internet.
The computing system may include clients and servers. A client and server are generally remote from each other and typically interact through a communication network. The relationship of client and server arises by virtue of computer programs running on the respective computers and having a client-server relationship to each other.
The subject matter described herein can be embodied in systems, apparatus, methods, and/or articles depending on the desired configuration. The implementations set forth in the foregoing description do not represent all implementations consistent with the subject matter described herein. Instead, they are merely some examples consistent with aspects related to the described subject matter. Although a few variations have been described in detail above, other modifications or additions are possible. In particular, further features and/or variations can be provided in addition to those set forth herein. For example, the implementations described above can be directed to various combinations and subcombinations of the disclosed features and/or combinations and subcombinations of several further features disclosed above. In addition, the logic flow(s) depicted in the accompanying figures and/or described herein do not necessarily require the particular order shown, or sequential order, to achieve desirable results. Other implementations may be within the scope of the following claims.
This application is a continuation of U.S. patent application Ser. No. 16/541,122 filed Aug. 14, 2019, which is a continuation application of U.S. patent application Ser. No. 15/352,897 filed Nov. 16, 2016 (now U.S. Pat. No. 10,420,926), which is a continuation application of U.S. patent application Ser. No. 13/802,231 filed Mar. 13, 2013 (now U.S. Pat. No. 10,143,830), the entire disclosures of each of which are herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1614703 | Delory | Nov 1898 | A |
3430625 | McLeod, Jr. | Mar 1969 | A |
4003252 | Dewath | Jan 1977 | A |
4415802 | Long | Nov 1983 | A |
4650475 | Smith et al. | Mar 1987 | A |
4853521 | Claeys et al. | Aug 1989 | A |
4857713 | Brown | Aug 1989 | A |
4921277 | McDonough | May 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
5011032 | Rollman | Apr 1991 | A |
5040422 | Frankenberger et al. | Aug 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5179862 | Lynnworth | Jan 1993 | A |
5190534 | Kendell | Mar 1993 | A |
5247826 | Frola et al. | Sep 1993 | A |
5279576 | Loo et al. | Jan 1994 | A |
5317506 | Coutre et al. | May 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5383858 | Reilly et al. | Jan 1995 | A |
5429602 | Hauser | Jul 1995 | A |
5463906 | Spani et al. | Nov 1995 | A |
5531697 | Olsen et al. | Jul 1996 | A |
5531698 | Olsen | Jul 1996 | A |
5569212 | Brown | Oct 1996 | A |
5611784 | Barresi et al. | Mar 1997 | A |
5612524 | Sant' Anselmo et al. | Mar 1997 | A |
5628309 | Brown | May 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5692640 | Caulfield et al. | Dec 1997 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5720733 | Brown | Feb 1998 | A |
5740428 | Mortimore et al. | Apr 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5782814 | Brown et al. | Jul 1998 | A |
5792117 | Brown | Aug 1998 | A |
5792120 | Menyhay | Aug 1998 | A |
5845264 | Nellhaus | Dec 1998 | A |
5873731 | Prendergast | Feb 1999 | A |
5882338 | Gray | Mar 1999 | A |
5920263 | Huttenhoff et al. | Jul 1999 | A |
5925014 | Teeple, Jr. | Jul 1999 | A |
5941846 | Duffy et al. | Aug 1999 | A |
5984901 | Sudo et al. | Nov 1999 | A |
6019745 | Gray | Feb 2000 | A |
6028433 | Cheiky-Zelina et al. | Feb 2000 | A |
6039251 | Holowko et al. | Mar 2000 | A |
6106498 | Friedli et al. | Aug 2000 | A |
6123686 | Olsen et al. | Sep 2000 | A |
6192945 | Ford et al. | Feb 2001 | B1 |
D438634 | Merry | Mar 2001 | S |
6249299 | Tainer | Jun 2001 | B1 |
6256037 | Callahan | Jul 2001 | B1 |
6270455 | Brown | Aug 2001 | B1 |
6277099 | Strowe et al. | Aug 2001 | B1 |
6338200 | Baxa et al. | Jan 2002 | B1 |
6341174 | Callahan et al. | Jan 2002 | B1 |
6342889 | Callahan | Jan 2002 | B1 |
6381029 | Tipirneni | Apr 2002 | B1 |
6422094 | Ganshorn | Jul 2002 | B1 |
6464667 | Kamen et al. | Oct 2002 | B1 |
6468424 | Donig et al. | Oct 2002 | B1 |
6471089 | Liff et al. | Oct 2002 | B2 |
6482185 | Hartmann | Nov 2002 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
6579231 | Phipps | Jun 2003 | B1 |
RE38189 | Walker et al. | Jul 2003 | E |
6585691 | Vitello | Jul 2003 | B1 |
6626355 | Sasse et al. | Sep 2003 | B2 |
6626862 | Duchon et al. | Sep 2003 | B1 |
D481121 | Evans | Oct 2003 | S |
6641562 | Peterson | Nov 2003 | B1 |
6644130 | Imai et al. | Nov 2003 | B2 |
6671563 | Engelson et al. | Dec 2003 | B1 |
D485356 | Evans | Jan 2004 | S |
6675660 | Mosier et al. | Jan 2004 | B1 |
6685227 | Merry et al. | Feb 2004 | B2 |
6685678 | Evans et al. | Feb 2004 | B2 |
6697067 | Callahan et al. | Feb 2004 | B1 |
6731989 | Engleson et al. | May 2004 | B2 |
6733495 | Bek et al. | May 2004 | B1 |
6742992 | Davis | Jun 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6798533 | Tipirneni | Sep 2004 | B2 |
6825864 | Botten et al. | Nov 2004 | B2 |
6851615 | Jones | Feb 2005 | B2 |
6854338 | Khuri-Yakub et al. | Feb 2005 | B2 |
6915170 | Engleson et al. | Jul 2005 | B2 |
6960192 | Flaherty et al. | Nov 2005 | B1 |
6985870 | Martucci et al. | Jan 2006 | B2 |
6993402 | Klass et al. | Jan 2006 | B2 |
7000485 | Ao et al. | Feb 2006 | B2 |
7017623 | Tribble et al. | Mar 2006 | B2 |
7061831 | De La Huerga | Jun 2006 | B2 |
7074205 | Duffy et al. | Jul 2006 | B1 |
7074209 | Evans et al. | Jul 2006 | B2 |
7096072 | Engleson et al. | Aug 2006 | B2 |
7103419 | Engleson et al. | Sep 2006 | B2 |
7106479 | Roy et al. | Sep 2006 | B2 |
7107106 | Engleson et al. | Sep 2006 | B2 |
7115113 | Evans et al. | Oct 2006 | B2 |
7116343 | Botten et al. | Oct 2006 | B2 |
7117041 | Engleson et al. | Oct 2006 | B2 |
7119689 | Mallett et al. | Oct 2006 | B2 |
7161488 | Frasch | Jan 2007 | B2 |
7171277 | Engleson et al. | Jan 2007 | B2 |
7175081 | Andreasson et al. | Feb 2007 | B2 |
7180624 | Tipirneni | Feb 2007 | B2 |
7182256 | Andreasson et al. | Feb 2007 | B2 |
7225683 | Harnett et al. | Jun 2007 | B2 |
7236936 | White et al. | Jun 2007 | B2 |
7237199 | Menhardt et al. | Jun 2007 | B1 |
7264323 | Tainer et al. | Sep 2007 | B2 |
7299981 | Hickle et al. | Nov 2007 | B2 |
7319540 | Tipirneni | Jan 2008 | B2 |
7347841 | Elhadad et al. | Mar 2008 | B2 |
7358505 | Woodworth et al. | Apr 2008 | B2 |
7360448 | Maginnis et al. | Apr 2008 | B2 |
7364067 | Steusloff et al. | Apr 2008 | B2 |
7370797 | Sullivan et al. | May 2008 | B1 |
7375737 | Botten et al. | May 2008 | B2 |
7384410 | Eggers et al. | Jun 2008 | B2 |
7442181 | Schubert et al. | Oct 2008 | B2 |
7452349 | Miyahara | Nov 2008 | B2 |
7469598 | Shkarlet et al. | Dec 2008 | B2 |
7469599 | Froehlich et al. | Dec 2008 | B2 |
7470266 | Massengale et al. | Dec 2008 | B2 |
7483756 | Engleson et al. | Jan 2009 | B2 |
D588200 | Langan et al. | Mar 2009 | S |
7534239 | Schneider et al. | May 2009 | B1 |
D593613 | Langan et al. | Jun 2009 | S |
D595361 | Langan et al. | Jun 2009 | S |
7559483 | Hickle et al. | Jul 2009 | B2 |
7564579 | Tipirneni | Jul 2009 | B2 |
D597608 | Langan et al. | Aug 2009 | S |
D602534 | Langan et al. | Oct 2009 | S |
7614545 | Christoffersen et al. | Nov 2009 | B2 |
7617739 | Dam | Nov 2009 | B1 |
D605228 | Langan et al. | Dec 2009 | S |
D605229 | Langan et al. | Dec 2009 | S |
D605230 | Langan et al. | Dec 2009 | S |
D607941 | Langan et al. | Jan 2010 | S |
7645258 | White et al. | Jan 2010 | B2 |
7668731 | Martucci et al. | Feb 2010 | B2 |
7673527 | Ehring et al. | Mar 2010 | B2 |
7694565 | Koerdt et al. | Apr 2010 | B2 |
7703336 | Genosar | Apr 2010 | B2 |
7704231 | Pongpairochana et al. | Apr 2010 | B2 |
7722083 | McCarthy et al. | May 2010 | B2 |
7727196 | Neer | Jun 2010 | B2 |
7753880 | Malackowski | Jul 2010 | B2 |
7753891 | Tennican et al. | Jul 2010 | B2 |
7756724 | Gropper et al. | Jul 2010 | B2 |
7763006 | Tennican | Jul 2010 | B2 |
D621879 | Langan et al. | Aug 2010 | S |
D621880 | Langan et al. | Aug 2010 | S |
7771385 | Eggers et al. | Aug 2010 | B2 |
D624595 | Langan et al. | Sep 2010 | S |
D624596 | Langan et al. | Sep 2010 | S |
7799010 | Tennican | Sep 2010 | B2 |
7813939 | Clements et al. | Oct 2010 | B2 |
7815123 | Conner et al. | Oct 2010 | B2 |
7815605 | Souter | Oct 2010 | B2 |
7819838 | Ziegler et al. | Oct 2010 | B2 |
7822096 | Kuksenkov | Oct 2010 | B2 |
7834816 | Marino et al. | Nov 2010 | B2 |
7859473 | Gibson | Dec 2010 | B2 |
D633151 | Langan et al. | Feb 2011 | S |
7887513 | Nemoto et al. | Feb 2011 | B2 |
D634367 | Langan et al. | Mar 2011 | S |
D634368 | Langan et al. | Mar 2011 | S |
D634369 | Langan et al. | Mar 2011 | S |
7905861 | Rhinehart et al. | Mar 2011 | B2 |
7918830 | Langan et al. | Apr 2011 | B2 |
7922073 | de la Huerga | Apr 2011 | B2 |
7927313 | Stewart et al. | Apr 2011 | B2 |
7933780 | De La Huerga | Apr 2011 | B2 |
7941949 | Cloninger | May 2011 | B2 |
D639861 | Langan et al. | Jun 2011 | S |
D639862 | Langan et al. | Jun 2011 | S |
D639863 | Langan et al. | Jun 2011 | S |
7967778 | Nemoto et al. | Jun 2011 | B2 |
D641421 | Langan et al. | Jul 2011 | S |
D641422 | Langan et al. | Jul 2011 | S |
7976508 | Hoag | Jul 2011 | B2 |
D643468 | Langan et al. | Aug 2011 | S |
D643469 | Langan et al. | Aug 2011 | S |
D643470 | Langan et al. | Aug 2011 | S |
D643472 | Langan et al. | Aug 2011 | S |
7991627 | Hutchinson et al. | Aug 2011 | B2 |
D645094 | Langan et al. | Sep 2011 | S |
8031347 | Edwards et al. | Oct 2011 | B2 |
8035517 | Gibson | Oct 2011 | B2 |
D649196 | Langan et al. | Nov 2011 | S |
8059297 | Tipirneni | Nov 2011 | B2 |
8063925 | Tainer et al. | Nov 2011 | B2 |
8065924 | Ziegler et al. | Nov 2011 | B2 |
8069060 | Tipirneni | Nov 2011 | B2 |
8111159 | Andreasson et al. | Feb 2012 | B2 |
8133178 | Brauker et al. | Mar 2012 | B2 |
8137303 | Stout et al. | Mar 2012 | B2 |
8140349 | Hanson et al. | Mar 2012 | B2 |
8151835 | Khan et al. | Apr 2012 | B2 |
8172082 | Edwards et al. | May 2012 | B2 |
8235938 | Eggers et al. | Aug 2012 | B2 |
8240550 | Steusloff et al. | Aug 2012 | B2 |
8303547 | Brown | Nov 2012 | B2 |
8328082 | Bochenko et al. | Dec 2012 | B1 |
8355753 | Bochenko et al. | Jan 2013 | B2 |
8385972 | Bochenko et al. | Feb 2013 | B2 |
8394053 | Bochenko et al. | Mar 2013 | B2 |
8480834 | Rice et al. | Jul 2013 | B2 |
8505809 | Steusloff et al. | Aug 2013 | B2 |
8606596 | Bochenko et al. | Dec 2013 | B1 |
8636202 | Keefe et al. | Jan 2014 | B2 |
8639521 | Eggers et al. | Jan 2014 | B2 |
8639525 | Levine et al. | Jan 2014 | B2 |
8645154 | Eggers et al. | Feb 2014 | B2 |
8702674 | Bochenko | Apr 2014 | B2 |
8752088 | Harvey et al. | Jun 2014 | B1 |
8808637 | Ferlic | Aug 2014 | B2 |
9216440 | Ma et al. | Dec 2015 | B2 |
9283369 | Ma et al. | Mar 2016 | B2 |
9931498 | Bochenko | Apr 2018 | B2 |
20010020148 | Sasse et al. | Sep 2001 | A1 |
20010049608 | Hochman | Dec 2001 | A1 |
20010056258 | Evans | Dec 2001 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020077852 | Ford et al. | Jun 2002 | A1 |
20020088131 | Baxa et al. | Jul 2002 | A1 |
20020098598 | Coffen et al. | Jul 2002 | A1 |
20020099334 | Hanson et al. | Jul 2002 | A1 |
20020161460 | Noguchi | Oct 2002 | A1 |
20020177811 | Reilly et al. | Nov 2002 | A1 |
20020188259 | Hickle et al. | Dec 2002 | A1 |
20030012701 | Sangha et al. | Jan 2003 | A1 |
20030052787 | Zerhusen et al. | Mar 2003 | A1 |
20030055685 | Cobb et al. | Mar 2003 | A1 |
20030065537 | Evans | Apr 2003 | A1 |
20030088238 | Poulsen et al. | May 2003 | A1 |
20030135388 | Martucci et al. | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030139706 | Gray | Jul 2003 | A1 |
20030140929 | Wilkes et al. | Jul 2003 | A1 |
20030160698 | Andreasson et al. | Aug 2003 | A1 |
20030164401 | Andreasson et al. | Sep 2003 | A1 |
20030174326 | Rzasa et al. | Sep 2003 | A1 |
20030199897 | Boecker et al. | Oct 2003 | A1 |
20030220599 | Lundtveit et al. | Nov 2003 | A1 |
20040051368 | Caputo et al. | Mar 2004 | A1 |
20040082918 | Evans et al. | Apr 2004 | A1 |
20040092885 | Duchon et al. | May 2004 | A1 |
20040103951 | Osborne et al. | Jun 2004 | A1 |
20040104271 | Martucci et al. | Jun 2004 | A1 |
20040105115 | Edwards et al. | Jun 2004 | A1 |
20040111078 | Miyahara | Jun 2004 | A1 |
20040179051 | Tainer et al. | Sep 2004 | A1 |
20040179132 | Fujino et al. | Sep 2004 | A1 |
20040186437 | Frenette et al. | Sep 2004 | A1 |
20040193453 | Butterfield et al. | Sep 2004 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040212834 | Edwards et al. | Oct 2004 | A1 |
20040238631 | Andreasson et al. | Dec 2004 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050070978 | Bek et al. | Mar 2005 | A1 |
20050088306 | Andreasson et al. | Apr 2005 | A1 |
20050101905 | Merry | May 2005 | A1 |
20050106225 | Massengale et al. | May 2005 | A1 |
20050107923 | Vanderveen | May 2005 | A1 |
20050118048 | Traxinger | Jun 2005 | A1 |
20050147524 | Bousquet | Jul 2005 | A1 |
20050151652 | Frasch | Jul 2005 | A1 |
20050151823 | Botten et al. | Jul 2005 | A1 |
20050154368 | Lim et al. | Jul 2005 | A1 |
20050165559 | Nelson | Jul 2005 | A1 |
20050182358 | Veit et al. | Aug 2005 | A1 |
20050197646 | Connell et al. | Sep 2005 | A1 |
20050277873 | Stewart et al. | Dec 2005 | A1 |
20050277890 | Stewart et al. | Dec 2005 | A1 |
20060032918 | Andreasson et al. | Feb 2006 | A1 |
20060065713 | Kingery | Mar 2006 | A1 |
20060079767 | Gibbs et al. | Apr 2006 | A1 |
20060079843 | Brooks et al. | Apr 2006 | A1 |
20060102503 | Elhadad et al. | May 2006 | A1 |
20060116639 | Russell | Jun 2006 | A1 |
20060122577 | Poulsen et al. | Jun 2006 | A1 |
20060143051 | Eggers et al. | Jun 2006 | A1 |
20060144942 | Evans et al. | Jul 2006 | A1 |
20060178617 | Adams et al. | Aug 2006 | A1 |
20060190302 | Eggers et al. | Aug 2006 | A1 |
20060206356 | Vanderveen | Sep 2006 | A1 |
20060212306 | Mallett et al. | Sep 2006 | A1 |
20060224125 | Simpson et al. | Oct 2006 | A1 |
20060226089 | Robinson et al. | Oct 2006 | A1 |
20060229551 | Martinez et al. | Oct 2006 | A1 |
20060253346 | Gomez | Nov 2006 | A1 |
20060258985 | Russell | Nov 2006 | A1 |
20060265186 | Holland et al. | Nov 2006 | A1 |
20060270997 | Lim et al. | Nov 2006 | A1 |
20060287887 | Hutchinson et al. | Dec 2006 | A1 |
20070008399 | Botten et al. | Jan 2007 | A1 |
20070043335 | Olsen et al. | Feb 2007 | A1 |
20070094303 | Zwingenberger et al. | Apr 2007 | A1 |
20070100316 | Traxinger | May 2007 | A1 |
20070112333 | Hoang et al. | May 2007 | A1 |
20070129708 | Edwards et al. | Jun 2007 | A1 |
20070134044 | Colbrunn et al. | Jun 2007 | A1 |
20070135765 | Miller et al. | Jun 2007 | A1 |
20070136218 | Bauer et al. | Jun 2007 | A1 |
20070166198 | Sangha et al. | Jul 2007 | A1 |
20070167919 | Nemoto et al. | Jul 2007 | A1 |
20070179448 | Lim et al. | Aug 2007 | A1 |
20070186923 | Poutiatine et al. | Aug 2007 | A1 |
20070187475 | MacLeod | Aug 2007 | A1 |
20070191787 | Lim et al. | Aug 2007 | A1 |
20070255199 | Dewey | Nov 2007 | A1 |
20070279625 | Rzasa et al. | Dec 2007 | A1 |
20070280710 | Tainer et al. | Dec 2007 | A1 |
20070286764 | Noguchi et al. | Dec 2007 | A1 |
20070293818 | Stout et al. | Dec 2007 | A1 |
20070293830 | Martin | Dec 2007 | A1 |
20070299421 | Gibson | Dec 2007 | A1 |
20080009783 | Branderburger et al. | Jan 2008 | A1 |
20080015492 | Biesel | Jan 2008 | A1 |
20080027399 | Harding et al. | Jan 2008 | A1 |
20080043088 | Botten et al. | Feb 2008 | A1 |
20080045930 | Makin et al. | Feb 2008 | A1 |
20080051937 | Khan et al. | Feb 2008 | A1 |
20080061153 | Hickle et al. | Mar 2008 | A1 |
20080071219 | Rhinehart et al. | Mar 2008 | A1 |
20080116908 | Potyrailo et al. | May 2008 | A1 |
20080118141 | Sommer et al. | May 2008 | A1 |
20080125724 | Monroe | May 2008 | A1 |
20080147047 | Davis et al. | Jun 2008 | A1 |
20080191013 | Liberatore | Aug 2008 | A1 |
20080208042 | Ortenzi et al. | Aug 2008 | A1 |
20080234630 | Iddan et al. | Sep 2008 | A1 |
20080243088 | Evans | Oct 2008 | A1 |
20080255523 | Grinberg | Oct 2008 | A1 |
20080294108 | Briones et al. | Nov 2008 | A1 |
20080306439 | Nelson et al. | Dec 2008 | A1 |
20080319795 | Poteet et al. | Dec 2008 | A1 |
20090008393 | Howlett et al. | Jan 2009 | A1 |
20090012448 | Childers et al. | Jan 2009 | A1 |
20090018494 | Nemoto et al. | Jan 2009 | A1 |
20090030730 | Dullemen et al. | Jan 2009 | A1 |
20090036846 | Dacquay et al. | Feb 2009 | A1 |
20090043253 | Podaima | Feb 2009 | A1 |
20090069714 | Eichmann et al. | Mar 2009 | A1 |
20090085768 | Patel et al. | Apr 2009 | A1 |
20090099552 | Levy et al. | Apr 2009 | A1 |
20090112178 | Behzadi | Apr 2009 | A1 |
20090112333 | Sahai | Apr 2009 | A1 |
20090126483 | Blendinger et al. | May 2009 | A1 |
20090126866 | Stenner et al. | May 2009 | A1 |
20090137956 | Souter | May 2009 | A1 |
20090143673 | Drost et al. | Jun 2009 | A1 |
20090149744 | Nemoto et al. | Jun 2009 | A1 |
20090156931 | Nemoto et al. | Jun 2009 | A1 |
20090157008 | Vitral | Jun 2009 | A1 |
20090159654 | Grimard | Jun 2009 | A1 |
20090171297 | Smith et al. | Jul 2009 | A1 |
20090200185 | Follman et al. | Aug 2009 | A1 |
20090259176 | Yairi | Oct 2009 | A1 |
20090288497 | Ziegler et al. | Nov 2009 | A1 |
20090294521 | de la Huerga | Dec 2009 | A1 |
20090296540 | Gilbert et al. | Dec 2009 | A1 |
20090306620 | Thilly et al. | Dec 2009 | A1 |
20100010443 | Morgan et al. | Jan 2010 | A1 |
20100022953 | Bochenko et al. | Jan 2010 | A1 |
20100022987 | Bochenko et al. | Jan 2010 | A1 |
20100036310 | Hillman | Feb 2010 | A1 |
20100036313 | Shener et al. | Feb 2010 | A1 |
20100056975 | Dale et al. | Mar 2010 | A1 |
20100065633 | Nelson et al. | Mar 2010 | A1 |
20100065643 | Leyvraz et al. | Mar 2010 | A1 |
20100076310 | Wenderow et al. | Mar 2010 | A1 |
20100095782 | Ferencz et al. | Apr 2010 | A1 |
20100114951 | Bauman et al. | May 2010 | A1 |
20100140342 | Deshays | Jun 2010 | A1 |
20100145165 | Merry | Jun 2010 | A1 |
20100145721 | Deshays | Jun 2010 | A1 |
20100152562 | Goodnow et al. | Jun 2010 | A1 |
20100153136 | Whittacre et al. | Jun 2010 | A1 |
20100174266 | Estes | Jul 2010 | A1 |
20100179417 | Russo | Jul 2010 | A1 |
20100204659 | Bochenko et al. | Aug 2010 | A1 |
20100245056 | Braun et al. | Sep 2010 | A1 |
20100262002 | Martz | Oct 2010 | A1 |
20100280486 | Khair et al. | Nov 2010 | A1 |
20100286599 | Ziegler et al. | Nov 2010 | A1 |
20100305499 | Matsiev et al. | Dec 2010 | A1 |
20110009800 | Dam et al. | Jan 2011 | A1 |
20110009817 | Bennett et al. | Jan 2011 | A1 |
20110028937 | Powers et al. | Feb 2011 | A1 |
20110054440 | Lewis | Mar 2011 | A1 |
20110060198 | Bennett et al. | Mar 2011 | A1 |
20110093279 | Levine et al. | Apr 2011 | A1 |
20110111794 | Bochenko et al. | May 2011 | A1 |
20110112473 | Bochenko et al. | May 2011 | A1 |
20110112474 | Bochenko et al. | May 2011 | A1 |
20110137288 | Tallarida et al. | Jun 2011 | A1 |
20110152824 | DiPerna et al. | Jun 2011 | A1 |
20110152825 | Marggi | Jun 2011 | A1 |
20110152834 | Langan et al. | Jun 2011 | A1 |
20110160655 | Hanson et al. | Jun 2011 | A1 |
20110161112 | Keefe et al. | Jun 2011 | A1 |
20110166511 | Sharvit et al. | Jul 2011 | A1 |
20110176490 | Mehta et al. | Jul 2011 | A1 |
20110185821 | Genosar | Aug 2011 | A1 |
20110220713 | Cloninger | Sep 2011 | A1 |
20110224649 | Duane et al. | Sep 2011 | A1 |
20110259954 | Bartz et al. | Oct 2011 | A1 |
20110264069 | Bochenko | Oct 2011 | A1 |
20110284024 | Trebella et al. | Nov 2011 | A1 |
20110313349 | Krulevitch et al. | Dec 2011 | A1 |
20110315611 | Fulkerson et al. | Dec 2011 | A1 |
20110317004 | Tao | Dec 2011 | A1 |
20120004542 | Nemoto et al. | Jan 2012 | A1 |
20120004602 | Hanson et al. | Jan 2012 | A1 |
20120004637 | Krulevitch et al. | Jan 2012 | A1 |
20120006127 | Nielsen | Jan 2012 | A1 |
20120022458 | Oh et al. | Jan 2012 | A1 |
20120035535 | Johnson et al. | Feb 2012 | A1 |
20120037266 | Bochenko | Feb 2012 | A1 |
20120041355 | Edman et al. | Feb 2012 | A1 |
20120046295 | Charrier et al. | Feb 2012 | A1 |
20120065617 | Matsiev et al. | Mar 2012 | A1 |
20120222468 | Nelson et al. | Sep 2012 | A1 |
20120226446 | Nelson et al. | Sep 2012 | A1 |
20120226447 | Nelson et al. | Sep 2012 | A1 |
20120287431 | Matsiev et al. | Nov 2012 | A1 |
20120325330 | Prince et al. | Nov 2012 | A1 |
20120323208 | Bochenko et al. | Dec 2012 | A1 |
20130018356 | Prince et al. | Jan 2013 | A1 |
20130030348 | Lauer | Jan 2013 | A1 |
20130105568 | Jablonski et al. | May 2013 | A1 |
20130181046 | Fedorko et al. | Jul 2013 | A1 |
20130204227 | Bochenko et al. | Aug 2013 | A1 |
20130225945 | Prince et al. | Aug 2013 | A1 |
20130226137 | Brown | Aug 2013 | A1 |
20130245604 | Kouyoumjian et al. | Sep 2013 | A1 |
20130327822 | Keefe et al. | Dec 2013 | A1 |
20140039383 | Dobbles et al. | Feb 2014 | A1 |
20140060729 | Srnka et al. | Mar 2014 | A1 |
20140142975 | Keefe et al. | May 2014 | A1 |
20150204705 | Forster et al. | Jul 2015 | A1 |
20150211904 | Forster | Jul 2015 | A1 |
20160015885 | Pananen et al. | Jan 2016 | A1 |
Number | Date | Country |
---|---|---|
29617777 | Jan 1997 | DE |
1980974 | Oct 2008 | EP |
2183046 | Nov 1989 | GB |
2504288 | Jan 2014 | GB |
2504295 | Jan 2014 | GB |
2504297 | Jan 2014 | GB |
S63260523 | Oct 1988 | JP |
H1176380 | Mar 1999 | JP |
2009219700 | Oct 2009 | JP |
2009537250 | Oct 2009 | JP |
WO-9910029 | Mar 1999 | WO |
WO-2006045214 | May 2006 | WO |
2009114115 | Sep 2009 | WO |
2010144482 | Dec 2010 | WO |
2012034084 | Mar 2012 | WO |
2014016311 | Jan 2014 | WO |
2014016315 | Jan 2014 | WO |
2014016316 | Jan 2014 | WO |
Number | Date | Country | |
---|---|---|---|
20210187268 A1 | Jun 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16541122 | Aug 2019 | US |
Child | 17172972 | US | |
Parent | 15352897 | Nov 2016 | US |
Child | 16541122 | US | |
Parent | 13802231 | Mar 2013 | US |
Child | 15352897 | US |